InvestorsHub Logo
Followers 6
Posts 348
Boards Moderated 0
Alias Born 05/22/2006

Re: bfiest post# 333531

Tuesday, 04/21/2020 4:01:09 AM

Tuesday, April 21, 2020 4:01:09 AM

Post# of 345995
We should not forget then everything the new crew has done. Like sell the IP for 8 million and 15% royalty, give away the exosome IP. If you think that it was a good deal to sell the IP to Oncologie, fine. It was a good deal for Oncologie. For 8 million they got Bavitaximab into two phase two advanced cancer trials with Mercks. Who wouldn't want that, 8 million for those two trials. Plus a third study for gliobastoma trial. Is Oncologie fronting any R&D like old PPHM did for $400 millions? It sure doesn't look so. And we obviously must love the transparency of it all.

Nobody knows yet what may come out of the exosomes science.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News